CareersInvestor RelationsPress RoomCOVID-19
  1. Home
  2. Medical Imaging
  3. Computed Tomography
Siemens Healthineers Computed Tomography

Computed TomographyYou think ahead. We innovate ahead.

NAEOTOM Alpha class hero image
Computed Tomography is moving beyond its traditional diagnostic role to become a key player in early disease detection and therapy planning. This expansion means an even broader patient cohort and resilient productivity demands. You need a reliable partner with products, services, and the infrastructure to support new business models and prioritize environmental sustainability and robustness. Computed Tomography at Siemens Healthineers, with its legacy of listening for almost 50 years, is innovating ahead of these developments, even before potentials become needs.

The NAEOTOM Alpha class

SOMATOM - Our conventional CT portfolio

Technologies & Innovation

Discover unique CT technologies for higher efficiency, exceptional imaging quality and consistent results.

News & Stories

A curved MPR image show the SVG with a VEST device anastomosed to the PDA. The middle segment appears thin. Two severe stenoses are visualized in the distal segment.

Subclavian steal syndrome

 2024-12-11

A 63-year-old male patient presented himself to the hospital, after a sudden onset of syncope, for a check-up. A Dual Energy CT angiography was performed on a Dual Source CT, SOMATOM Pro.Pulse, to rule out suspected bilateral carotid artery stenoses.

Clinical Results
A small lesion in the pancreatic body is seen in a cinematic VRT image created with UHR images.

Pancreatic insulinoma in a patient with a history of hypoglycemia

 2024-11-27

A 63-year-old female patient, with a history of Hypoglycemia, had a calcium stimulation challenge test which showed diffuse insulin secretion throughout the pancreas, suspecting an insulinoma. However, a conventional CT examination did not reveal any pancreatic lesion. A contrast CT scan was performed with NAEOTOM Alpha for further evaluation.

Clinical Results
A curved MPR image show the SVG with a VEST device anastomosed to the PDA. The middle segment appears thin. Two severe stenoses are visualized in the distal segment.

Severe stenoses in a coronary saphenous vein graft with an external VEST support

 2024-11-13

A 59-year-old male patient, with a history of triple CABG and coronary stenting, came to the hospital with non-specific symptoms. A CT scan with a dual source photon-counting detector CT, NAEOTOM Alpha®, was performed to evaluate the patency of the grafts, the anastomoses and the stent.

Clinical Results
A cinematic VRT image shows a three-dimensional view of the tumor located in the pancreatic body, showing no evidence of gastric wall invasion

A well-differentiated, invasive ductal adenocarcinoma in the pancreatic body

 2024-10-30

A 69-year-old male patient, complaining of abdominal pain slowly progressing over the past 3 months, came to the hospital for a check-up. Ultrasound examination revealed a mixed solid and cystic mass in the pancreatic body, with suspicious invasion into the gastric wall. A CT examination was performed with a photon-counting CT, NAEOTOM Alpha®, for further assessment.

Clinical Results
Two corresponding curved MPR images, using standard and ZeeFree reconstruction, demonstrate a clear visualization of mild stenoses in the proximal LAD, caused by calcified plaques, after the ZeeFree correction. A non-calcified plaque in the mid LAD is also seen.

Multi-vessel coronary atherosclerosis – significant stenoses?

 2024-10-16

A 78-year-old female diabetic patient, with clinical symptoms of a suspected stable angina, came to the hospital for a check-up. A coronary CT angiography was requested to evaluate the coronary arteries and to rule out coronary stenosis. A prospectively ECG-triggered sequential mode was performed with a dual source photon-counting detector CT, NAEOTOM Alpha®.

Clinical Results
NAEOTOM Alpha.Prime, NAEOTOM Alpha.Pro and NAEOTOM ALpha.Peak are pending 510(k) clearance and are not yet commercially available in the United States and other regions.
The products/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed.
1
For research use only. Not for clinical use.